Moreover, we found that a quarter of breast cancer patients harbor RSPO2/RSPO3 copy number amplification, which is associated with worse prognosis and lack of steroid hormone receptor expression, restricting therapeutic options. The gene discussed is RSPO2; the disease is breast carcinoma.